{
  "@context": "http://id.who.int/icd/contexts/contextForLinearizationEntity.json",
  "@id": "http://id.who.int/icd/release/11/2024-01/mms/1901756287",
  "parent": [
    "http://id.who.int/icd/release/11/2024-01/mms/1658448496"
  ],
  "browserUrl": "https://icd.who.int/browse/2024-01/mms/en#1901756287",
  "code": "2A20.3",
  "source": "http://id.who.int/icd/entity/1901756287",
  "classKind": "category",
  "postcoordinationScale": [
    {
      "@id": "http://id.who.int/icd/release/11/2024-01/mms/1901756287/postcoordinationScale/hasManifestation",
      "axisName": "http://id.who.int/icd/schema/hasManifestation",
      "requiredPostcoordination": "false",
      "allowMultipleValues": "AllowAlways",
      "scaleEntity": [
        "http://id.who.int/icd/release/11/2024-01/mms/322466810"
      ]
    }
  ],
  "title": {
    "@language": "en",
    "@value": "Chronic eosinophilic leukaemia, not elsewhere classified"
  },
  "definition": {
    "@language": "en",
    "@value": "A chronic myeloproliferative neoplasm characterised by persistent eosinophilia in the blood, bone marrow and peripheral tissues. Organ damage occurs as a result of leukaemic infiltration or the release of cytokines, enzymes or other proteins by the eosinophils. Chronic eosinophilic leukaemia, not otherwise specified excludes patients with a Ph chromosome, BCR-ABL1 fusion gene or rearrangement of PDGFRA, PDGFRB or FGFR1."
  },
  "indexTerm": [
    {
      "label": {
        "@language": "en",
        "@value": "Chronic eosinophilic leukaemia, not elsewhere classified"
      }
    }
  ]
}